OPKO Health Unit Providing Coronavirus Antibody Screening in New York City

OPKO Health (NASDAQ: OPK), which is on the forefront of testing for COVID-19 and the SARS-CoV-2 coronavirus that causes it, is helping New York City get a handle on how the disease has been spreading through the five boroughs. On Friday, the company's BioReference lab testing subsidiary launched a large-scale SARS-CoV-2 antibody screening service for residents of the city, which was hit particularly hard by the pandemic.

In the opening phases of the project, 140,000 of the municipality's residents will be tested in five locations, one in each of its five boroughs. In the next few weeks, other testing sites are to be opened; OPKO Health did not get any more specific.

Image source: Getty Images.

Continue reading

Source Fool.com